Cargando…

Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study

BACKGROUND: According to guidelines, all patients with sarcoma must be managed from initial diagnosis at expert sarcoma centers. However, in everyday practice, the time interval to an expert center visit can be long, which delays presentation to an expert multidisciplinary tumor board and increases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nannini, Simon, Penel, Nicolas, Bompas, Emmanuelle, Willaume, Thibault, Kurtz, Jean-Emmanuel, Gantzer, Justine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685503/ https://www.ncbi.nlm.nih.gov/pubmed/36350680 http://dx.doi.org/10.2196/40718

Ejemplares similares

Natural History and Treatment Strategies of Advanced PEComas: A Systematic Review
por: Bourgmayer, Agathe, et al.
Publicado: (2021)

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma
por: Maillard, Maud, et al.
Publicado: (2020)

Delays in Referral of Soft Tissue Sarcomas
por: Johnson, G. D., et al.
Publicado: (2008)

Patterns of care and outcome of CIC‐rearranged sarcoma patients: A nationwide study of the French sarcoma group
por: Brahmi, Mehdi, et al.
Publicado: (2022)

High Prevalence of 5T4/Trophoblast Glycoprotein in Soft Tissue Sarcomas
por: Groothuis, Patrick, et al.
Publicado: (2021)

The Effectiveness of “Two-Week” Referrals for Suspected Bone and Soft Tissue Sarcoma
por: Malik, A., et al.
Publicado: (2007)

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO)
por: Lebellec, Loic, et al.
Publicado: (2016)

Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review
por: Sharma, Sheetal, et al.
Publicado: (2013)

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases
por: Penel, Nicolas, et al.
Publicado: (2008)

Shortening of ventriculoatrial interval after ablation of an accessory pathway
por: Alasti, Mohammad, et al.
Publicado: (2006)

Shortening of Subjective Visual Intervals Followed by Repetitive Stimulation
por: Ono, Fuminori, et al.
Publicado: (2011)

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
por: Brodowicz, Thomas, et al.
Publicado: (2015)

Assessment of Referrals into the Soft Tissue Sarcoma Service: Evaluation of Imaging Early in the Pathway Process
por: Rowbotham, Emma, et al.
Publicado: (2012)

A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome
por: Rochefort, Pauline, et al.
Publicado: (2017)

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)
por: Patrikidou, Anna, et al.
Publicado: (2020)

Evaluation of Soft Tissue Mobilization in Patients with Temporomandibular Disorder-Myofascial Pain with Referral
por: Kuć, Joanna, et al.
Publicado: (2020)

Determinants of the access to remote specialised services provided by national sarcoma reference centres
por: Fayet, Yohan, et al.
Publicado: (2021)

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study
por: Penel, N, et al.
Publicado: (2011)

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study
por: Brodowicz, Thomas, et al.
Publicado: (2020)

The off-label use of targeted therapies in sarcomas: the OUTC’S program
por: Eberst, Lauriane, et al.
Publicado: (2014)

The Real-Life Journey of Elderly Patients in Soft Tissue and Bone Sarcomas: A Retrospective Analysis from a Sarcoma Referral Center
por: Ferraresi, Virginia, et al.
Publicado: (2020)

QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization
por: Keirns, J, et al.
Publicado: (2017)

Soft Tissue Sarcomas: A 16-Year Experience of a Tertiary Referral Hospital in North Jordan
por: Alorjani, Mohammed S., et al.
Publicado: (2022)

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
por: Blay, Jean-Yves, et al.
Publicado: (2013)

Ether à go-go potassium channel expression in soft tissue sarcoma patients
por: Mello de Queiroz, Fernanda, et al.
Publicado: (2006)

Radiation Therapy in Adult Soft Tissue Sarcoma—Current Knowledge and Future Directions: A Review and Expert Opinion
por: Roeder, Falk
Publicado: (2020)

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas
por: Brahmi, M., et al.
Publicado: (2021)

REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis
por: Berry, Vincent, et al.
Publicado: (2017)

Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials
por: Cren, Pierre-Yves, et al.
Publicado: (2020)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Role of expert centres in the management of sarcomas
por: Judson, Ian
Publicado: (2013)

Exercise-related leg muscle signal changes: assessment using diffusion-weighted MRI
por: Kolmer, Floriane, et al.
Publicado: (2023)

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
por: Cassier, P A, et al.
Publicado: (2013)

Retraction: On soft expert topological spaces
por: Hussain, Sabir, et al.
Publicado: (2012)

The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
por: Trovik, Clement, et al.
Publicado: (2017)

Genomic profiling of a metastatic anaplastic melanocytic neuroectodermal tumor arising from a mature thymic teratoma as part of a mediastinal germ cell tumor
por: Mayeur, Sylvain, et al.
Publicado: (2023)

Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions
por: Ali, Sheikh Taslim, et al.
Publicado: (2020)

Application of the Plan–Do–Check–Act Cycle in Shortening the Decision to Delivery Interval Time
por: Lu, Ming-Na, et al.
Publicado: (2022)

Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol
por: le Guevelou, Jennifer, et al.
Publicado: (2020)

Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years
por: Basse, Clémence, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mhtfkv9np6ai9n8p14fmpbio19